Envoy Medical, Inc.

Anzu Special Acquisition Corp I (Nasdaq: ANZU) was a blank-check company sponsored by Anzu Partners, a venture and growth equity firm focused on deep technology. The SPAC completed its initial public offering in 2021 with a mandate to target the technology sector. It subsequently announced a business combination with Envoy Medical, Inc., a medical technology company known for its fully implantable hearing system. The transaction closed in 2023, bringing Envoy Medical to the public markets. The deal is now marked as closed. Sign up for full data on ANZU, Envoy Medical, and the broader SPAC universe at SpacDesk.

SPAC Counterparty (1)